Next Article in Journal
Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission
Previous Article in Journal
An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications
Previous Article in Special Issue
Cancer Genome Sequencing and Its Implications for Personalized Cancer Vaccines
Article

Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy

1
Department of Immunology, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria 3004, Australia
2
Department of Oncology, Royal Women’s Hospital, Melbourne, Victoria 3052, Australia
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2012, 4(2), 581-600; https://doi.org/10.3390/cancers4020581
Received: 18 May 2012 / Revised: 13 June 2012 / Accepted: 14 June 2012 / Published: 18 June 2012
(This article belongs to the Special Issue Cancer Vaccines and Immunotherapy)
Ovarian cancer is the leading cause of death from gynaecological malignancy. Despite improved detection and treatment options, relapse rates remain high. Combining immunotherapy with the current standard treatments may provide an improved prognosis, however, little is known about how standard chemotherapy affects immune potential (particularly T cells) over time, and hence, when to optimally combine it with immunotherapy (e.g., vaccines). Herein, we assess the frequency and ratio of CD8+ central memory and effector T cells as well as CD4+ effector and regulatory T cells (Tregs) during the first 18 weeks of standard chemotherapy for ovarian cancer patients. In this pilot study, we observed increased levels of recently activated Tregs with tumor migrating ability (CD4+CD25hiFoxp3+CD127−CCR4+CD38+ cells) in patients when compared to controls. Although frequency changes of Tregs as well as the ratio of effector T cells to Tregs were observed during treatment, the Tregs consistently returned to pre-chemotherapy levels at the end of treatment. These results indicate T cell subset distributions associated with recurrence may be largely resistant to being “re-set” to healthy control homeostatic levels following standard treatments. However, it may be possible to enhance T effector to Treg ratios transiently during chemotherapy. These results suggest personalized immune monitoring maybe beneficial when combining novel immuno-therapeutics with standard treatment for ovarian cancer patients. View Full-Text
Keywords: CD4+ T cells; CD8 T cells; regulatory T cells; ovarian cancer CD4+ T cells; CD8 T cells; regulatory T cells; ovarian cancer
Show Figures

Figure 1

MDPI and ACS Style

Park, A.; Govindaraj, C.; Xiang, S.D.; Halo, J.; Quinn, M.; Scalzo-Inguanti, K.; Plebanski, M. Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy. Cancers 2012, 4, 581-600. https://doi.org/10.3390/cancers4020581

AMA Style

Park A, Govindaraj C, Xiang SD, Halo J, Quinn M, Scalzo-Inguanti K, Plebanski M. Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy. Cancers. 2012; 4(2):581-600. https://doi.org/10.3390/cancers4020581

Chicago/Turabian Style

Park, Anthony, Chindu Govindaraj, Sue D. Xiang, Julene Halo, Michael Quinn, Karen Scalzo-Inguanti, and Magdalena Plebanski. 2012. "Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy" Cancers 4, no. 2: 581-600. https://doi.org/10.3390/cancers4020581

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop